Alexander Harvey
Cardiovascular Disease · Oklahoma City, OKNPI 1083119515
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,499 of the $8,203 with a category attached, or 67.0%. 20 manufacturers reported payments, led by Medtronic at 43.6% of the total. 2025 is the largest year on record at $4,305, more than ten times the $182 reported in 2021.
Across 122 payments — averaging $67.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abiomed$931
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$841
- Philips North America LLC$345
- Biosense Webster, Inc.$343
- Shockwave Medical, Inc$338
- plus $2K from 14 others
What the payments were for
- Travel & lodging$2,33228%
- Food & beverage$5,49967%
- Education$3715%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 48 | $3,573 |
| Abiomed | 8 | $931 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 20 | $841 |
| Philips North America LLC | 3 | $345 |
| Biosense Webster, Inc. | 6 | $343 |
| Shockwave Medical, Inc | 3 | $338 |
| Pfizer | 6 | $257 |
| Angiodynamics, Inc. | 2 | $229 |
| Alnylam Pharmaceuticals Inc. | 2 | $206 |
| Abbott | 3 | $177 |
| Boston Scientific | 2 | $168 |
| Chiesi USA, Inc. | 3 | $140 |
| Sanofi-aventis U.S. LLC | 1 | $125 |
| Novartis | 4 | $124 |
| Cardiva Medical, Inc. | 5 | $106 |
| Actelion Pharmaceuticals US, Inc. | 1 | $100 |
| Teleflex LLC | 1 | $84 |
| Impulse Dynamics (USA) Inc. | 1 | $62 |
| Irhythm Technologies, Inc. | 2 | $38 |
| Cordis US CORP. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$894
- Carto 3$304
- AlphaVac$229
- (9124) LM Undivided$215
- LifeVest$214
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$171
- SelectSecure$169
- Micra$152
- WATCHMAN Access System$138
- VYNDAQEL$125
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$122
- KENGREAL$112
- AMVUTTRA$109
- LINQ II$108
How this compares
$8,203 in reported general payments places this provider in the 80th percentile of 164 cardiovascular disease providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spironolactone | 14 | $61 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Oklahoma City
- Aly El BanayosyOklahoma City$54K
- Dwight ReynoldsOklahoma City$47K
- Udho ThadaniOklahoma City$41K
- Robert SullivanOklahoma City$36K
- Reji PappyOklahoma City$25K
- Sandeep ChopraOklahoma City$15K
- Jered CookOklahoma City$14K
- William CollazoOklahoma City$11K
- Vinodh JeevananthamOklahoma City$11K
- Niraj PrasadOklahoma City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.